ALBIREO PHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Albireo Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2021.
  • Albireo Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $3.55M, a 47.1% decline year-over-year.
  • Albireo Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $13.2M, a 25.7% decline year-over-year.
  • Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.9M, a 9% increase from 2020.
  • Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $14.6M, a 92.9% increase from 2019.
  • Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $7.58M, a 36.6% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $15.9M +$1.32M +9% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-01
2020 $14.6M +$7.04M +92.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $7.58M +$2.03M +36.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $5.55M +$1.85M +49.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $3.7M +$2.56M +225% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $1.14M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.